Volume 24, Issue 1, August 2018, Pages 359–367
THES Pehie Marie Epse SOUMAHORO1, OUATTARA Sitapha2, KPOROU Kouassi Elisée3, KRA Adou Koffi Mathieu4, and Djaman Allico Joseph5
1 Biochemical Pharmacodynamics laboratory, University Felix Houphouët Boigny, Côte d’Ivoire
2 Biochemical Pharmacodynamics laboratory, University Felix Houphouët Boigny, Côte d’Ivoire
3 Biochemical Pharmacodynamics laboratory, University Felix Houphouët Boigny, Côte d’Ivoire
4 Biochemical Pharmacodynamics laboratory, University Felix Houphouët Boigny, Côte d’Ivoire
5 Pharmacodynamics Biochemical Laboratory, UFR Biosciences, Felix Houphouet Boigny University, PO BOX, 582 Abidjan 22, Côte d’Ivoire
Original language: English
Copyright © 2018 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
We studied the cutaneous MISCA-MATES toxicity soap humans. The test of irritation at the man is indispensable to specify the potential irritating power of some better cosmetic preparations. Thirty soaps of MISCA-MATÈS experimentation were delayed on thirty voluntary people. Two methods have been used. The first consists in applying a quantity of soap foam on the hand of the volunteers during 24 hours. The test has been repeated at the same place during 7 days except if an erythema develops in which case the test is stopped. The treatment has not been interrupted after the 7 days of experimentation. The second method consists in distributing to each volunteer a soap for the bath during 7 days and we noted the effects which could produce the soap on their respective skins. The analysis shows that one person out of thirty (3.33 %) felt a slight burn when applying soap while twenty nine persons (96.67 %) felt no burn.
Author Keywords: toxicity, erythema, MISCA-MATÈS soap.
THES Pehie Marie Epse SOUMAHORO1, OUATTARA Sitapha2, KPOROU Kouassi Elisée3, KRA Adou Koffi Mathieu4, and Djaman Allico Joseph5
1 Biochemical Pharmacodynamics laboratory, University Felix Houphouët Boigny, Côte d’Ivoire
2 Biochemical Pharmacodynamics laboratory, University Felix Houphouët Boigny, Côte d’Ivoire
3 Biochemical Pharmacodynamics laboratory, University Felix Houphouët Boigny, Côte d’Ivoire
4 Biochemical Pharmacodynamics laboratory, University Felix Houphouët Boigny, Côte d’Ivoire
5 Pharmacodynamics Biochemical Laboratory, UFR Biosciences, Felix Houphouet Boigny University, PO BOX, 582 Abidjan 22, Côte d’Ivoire
Original language: English
Copyright © 2018 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
We studied the cutaneous MISCA-MATES toxicity soap humans. The test of irritation at the man is indispensable to specify the potential irritating power of some better cosmetic preparations. Thirty soaps of MISCA-MATÈS experimentation were delayed on thirty voluntary people. Two methods have been used. The first consists in applying a quantity of soap foam on the hand of the volunteers during 24 hours. The test has been repeated at the same place during 7 days except if an erythema develops in which case the test is stopped. The treatment has not been interrupted after the 7 days of experimentation. The second method consists in distributing to each volunteer a soap for the bath during 7 days and we noted the effects which could produce the soap on their respective skins. The analysis shows that one person out of thirty (3.33 %) felt a slight burn when applying soap while twenty nine persons (96.67 %) felt no burn.
Author Keywords: toxicity, erythema, MISCA-MATÈS soap.
How to Cite this Article
THES Pehie Marie Epse SOUMAHORO, OUATTARA Sitapha, KPOROU Kouassi Elisée, KRA Adou Koffi Mathieu, and Djaman Allico Joseph, “Acute toxicity’s survey of the MISCA-MATÈS soap,” International Journal of Innovation and Applied Studies, vol. 24, no. 1, pp. 359–367, August 2018.
